Muhammed Hammad

University of California, Irvine

Papers

2

Total Citations

7

H-Index

2

About

Dr. Muhammed Hammad is a rising authority in urologic surgery and transplantation, with a focused research program that leverages robotic-assisted technologies to improve surgical outcomes. His work centers on two critical areas: advancing minimally invasive approaches in kidney transplantation and optimizing perioperative care for prostate cancer surgery. In his landmark 2025 systematic review and meta-analysis of propensity-matched studies, Dr. Hammad rigorously compared robotic-assisted versus open kidney transplantation, providing the highest level of evidence to date on the safety and efficacy of the robotic approach—a contribution that has already garnered 5 citations in a short period. His 2024 meta-analysis on outpatient versus inpatient robot-assisted radical prostatectomy (RARP) tackled a pressing question in surgical urology: whether same-day discharge compromises patient safety. By synthesizing multi-institutional data, he demonstrated that outpatient RARP can be performed without increased complications, challenging traditional inpatient protocols and paving the way for cost-effective, patient-centered care. Though early in his career, Dr. Hammad’s methodologically robust meta-analyses are shaping clinical guidelines and inspiring further prospective trials, marking him as a researcher to watch in the evolution of robotic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-Assisted vs Open Kidney Transplantation: A Systematic Review and Meta-Analysis of Propensity-Matched Studies
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: University of California, Irvine

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago